[HTML][HTML] TGF-β signaling-related genes and thoracic aortic aneurysms and dissections
N Takeda, H Hara, T Fujiwara, T Kanaya… - International journal of …, 2018 - mdpi.com
Transforming growth factor-β (TGF)-β signaling plays a crucial role in the development and
maintenance of various organs, including the vasculature. Accordingly, the mutations in TGF …
maintenance of various organs, including the vasculature. Accordingly, the mutations in TGF …
Therapies for thoracic aortic aneurysms and acute aortic dissections: old controversies and new opportunities
DM Milewicz, F Ramirez - Arteriosclerosis, Thrombosis, and …, 2019 - Am Heart Assoc
Thoracic aortic aneurysms that progress to acute aortic dissections are often fatal. Thoracic
aneurysms have been managed with treatment with β-adrenergic blocking agents (β …
aneurysms have been managed with treatment with β-adrenergic blocking agents (β …
[HTML][HTML] Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO
A de la Fuente-Alonso, M Toral, A Alfayate… - Nature …, 2021 - nature.com
Thoracic aortic aneurysm, as occurs in Marfan syndrome, is generally asymptomatic until
dissection or rupture, requiring surgical intervention as the only available treatment. Here …
dissection or rupture, requiring surgical intervention as the only available treatment. Here …
Marfan syndrome
DM Milewicz, AC Braverman, J De Backer… - Nature reviews Disease …, 2021 - nature.com
Marfan syndrome (MFS) is an autosomal dominant, age-related but highly penetrant
condition with substantial intrafamilial and interfamilial variability. MFS is caused by …
condition with substantial intrafamilial and interfamilial variability. MFS is caused by …
Loeys-dietz syndrome
JD Velchev, L Van Laer, I Luyckx, H Dietz… - Progress in Heritable Soft …, 2021 - Springer
Loeys-Dietz syndrome is an autosomal dominant aortic aneurysm syndrome characterized
by multisystemic involvement. The most typical clinical triad includes hypertelorism, bifid …
by multisystemic involvement. The most typical clinical triad includes hypertelorism, bifid …
[HTML][HTML] Pathophysiology and therapeutics of thoracic aortic aneurysm in Marfan syndrome
K Asano, A Cantalupo, L Sedes, F Ramirez - Biomolecules, 2022 - mdpi.com
About 20% of individuals afflicted with thoracic aortic disease have single-gene mutations
that predispose the vessel to aneurysm formation and/or acute aortic dissection often without …
that predispose the vessel to aneurysm formation and/or acute aortic dissection often without …
[HTML][HTML] Endothelial dysfunction in Marfan syndrome mice is restored by resveratrol
A Mieremet, M van der Stoel, S Li, E Coskun… - Scientific reports, 2022 - nature.com
Patients with Marfan syndrome (MFS) develop thoracic aortic aneurysms as the aorta
presents excessive elastin breaks, fibrosis, and vascular smooth muscle cell (vSMC) death …
presents excessive elastin breaks, fibrosis, and vascular smooth muscle cell (vSMC) death …
The NO signalling pathway in aortic aneurysm and dissection
M Toral, A de la Fuente‐Alonso… - British Journal of …, 2022 - Wiley Online Library
Recent studies have shown that NO is a central mediator in diseases associated with
thoracic aortic aneurysm, such as Marfan syndrome. The progressive dilation of the aorta in …
thoracic aortic aneurysm, such as Marfan syndrome. The progressive dilation of the aorta in …
[HTML][HTML] Senkyunolide I ameliorates thoracic aortic aneurysm and dissection in mice via inhibiting the oxidative stress and apoptosis of endothelial cells
K Zhao, H Zhu, X He, P Du, T Liang, Y Sun… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Background Thoracic aortic aneurysm and aortic dissection (TAAD) is one of the most fatal
cardiovascular diseases. Senkyunolide I (SEI) is a component of traditional Chinese …
cardiovascular diseases. Senkyunolide I (SEI) is a component of traditional Chinese …
[HTML][HTML] Respiratory manifestations of Marfan syndrome: a narrative review
MH Tun, B Borg, M Godfrey… - Journal of Thoracic …, 2021 - ncbi.nlm.nih.gov
Objective The prevalence of Marfan syndrome (MFS) is estimated to be 1 in 10,000 to
15,000 individuals, but the phenotype of MFS may not be apparent and hence its diagnosis …
15,000 individuals, but the phenotype of MFS may not be apparent and hence its diagnosis …